Research Paper Volume 15, Issue 16 pp 8298—8314

Gastrodin ameliorates cognitive dysfunction in diabetes by inhibiting PAK2 phosphorylation

class="figure-viewer-img"

Figure 2. The transcriptomic profile of Gastrodin intervention on the hippocampus of diabetic rats and further confirmation. (A) Differentially expressed genes among NC9w, DM9w+S, DM9w+G60 and DM9w+G120 group. (B) Volcano plot of all genes based on their log2 fold-change and adjusted P-values between NC9w and DM9w+S group. Differentially expressed genes were classified at an adjusted P-value of < 0.05. (C) The KEGG pathways enriched between NC9w and DM9w+S group. The rich factor refers to the ratio of the number of DEGs to the number of total annotated genes in a certain pathway. (DH) qPCR analysis of the mRNA expression of PAK2 (D) Mrpl1 (E) Sp8 (F) RagA (G) and RagB (H) in the hippocampus of the NC9w, DM9w+S, DM9w+G60 and DM9w+G120 groups. *p < 0.05 and **p < 0.01.